Jasper Share Price

Jasper Share Price

NASDAQ: JSPR | Micro Cap | Healthcare
$12.01
+$1.39 (13.14%) Last updated on 18 Nov, 2026 | 23:43 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Jasper Stock Performance

Open
$10.88
Prev. Close
$10.62
Circuit Range
N/A
Day Range
$10.88 - $10.88
Year Range
$0.32 - $16.63
Volume
150
Average Traded
$10.88

Jasper Share Price Today

As of 19 November 2026, Jasper Therapeutics, Inc.'s share price is $12.01. The stock opened at $10.88, compared to its previous close of $10.62. During today's trading session, Jasper Therapeutics, Inc.'s share price traded between $10.88 and $10.88, with an average price of $10.88. Over the past 52 weeks, the stock has recorded a high of $16.63 and a low of $0.32. In terms of performance, Jasper Therapeutics, Inc.'s share price has risen by 1324.67% over the last six months and is up 559.89% on a year-on-year basis.

Jasper Share Price Chart

Line chart of the Jasper price trend over the selected period. The price rose overall, ranging from 10.62 to 12.01, ending at 12.01.
$10.88$10.88
L
Show Current Price
H

Jasper Stock Fundamentals & Key Indicators

Market Cap
$230.21M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-28.62
Revenue (TTM)
$0.00
Return On Equity (TTM)
-2248.48%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
85.27%

Jasper Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.74-$9.10-$1.17-$2.76
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A51.44%87.14%-135.90%

Jasper Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$37.69-$64.47-$71.27-$75.80
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-71.05%-10.55%-6.36%

Jasper Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.134.095.956.63
Current Assets34.6575.8188.9441.73
Total Assets35.7879.994.8948.36
Non Current Liabilities18.432.994.085.16
Current Liabilities13.215.2412.377.07
Total Liabilities31.6318.2316.4512.22
Shareholders' Equity4.1561.6778.4436.14

Jasper Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-77.16-62.6-52.07-45.86
Investing0.01-0.53-0.27-0.58
Financing34.2147.88100.970.06

Corporate Actions

Split
Ex-date: 06 Nov 2026

Split
Ex-date: 04 Jan 2024

About Jasper

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Jasper Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.54
$10.88
+1,972.38%
Oct 2026
$0.61
$0.53
-9.33%
Sep 2026
$0.70
$0.58
-17.40%
Aug 2026
$0.61
$0.70
+10.92%
Jul 2026
$0.41
$0.63
+48.36%
Jun 2026
$0.85
$0.43
-49.47%
May 2026
$0.93
$0.84
-9.55%
Apr 2026
$0.89
$0.93
+7.25%
Mar 2026
$1.33
$0.87
-37.03%
Feb 2026
$1.48
$1.38
-5.80%
Jan 2026
$1.83
$1.47
-19.51%
Dec 2025
$1.80
$1.82
+0.00%

Jasper Share Price FAQs